Literature DB >> 3871326

Primary CNS lymphoma in the cerebellopontine angle. Report of a case.

A Ierokomos, D W Goin.   

Abstract

We report a case of primary CNS lymphoma that appeared as a cerebellopontine angle lesion, an initial observation not previously reported, to our knowledge. In general, primary CNS lymphoma remains localized to the CNS, with death occurring from localized recurrence. Radiation therapy after open biopsy is the treatment of choice, and achieves a good three-year outcome. However, five-year outcome with this treatment is poor.

Entities:  

Mesh:

Year:  1985        PMID: 3871326     DOI: 10.1001/archotol.1985.00800030084012

Source DB:  PubMed          Journal:  Arch Otolaryngol        ISSN: 0003-9977


  4 in total

1.  Lymphomatous meningitis: neuroradiological appearances.

Authors:  A Donnet; G Moulin; N Tubiana; R Gras; J L Robert
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

Review 2.  [Primary B-cell non-Hodgkin lymphoma of the internal auditory canal: case report and literature review].

Authors:  F B Knapp; E Rieh; J Spreer; T Klenzner; W Maier
Journal:  HNO       Date:  2008-06       Impact factor: 1.284

3.  Rapid Automated Analysis of Skull Base Tumor Specimens Using Intraoperative Optical Imaging and Artificial Intelligence.

Authors:  Cheng Jiang; Abhishek Bhattacharya; Joseph R Linzey; Rushikesh S Joshi; Sung Jik Cha; Sudharsan Srinivasan; Daniel Alber; Akhil Kondepudi; Esteban Urias; Balaji Pandian; Wajd N Al-Holou; Stephen E Sullivan; B Gregory Thompson; Jason A Heth; Christian W Freudiger; Siri Sahib S Khalsa; Donato R Pacione; John G Golfinos; Sandra Camelo-Piragua; Daniel A Orringer; Honglak Lee; Todd C Hollon
Journal:  Neurosurgery       Date:  2022-03-30       Impact factor: 5.315

4.  HIV-associated cerebral lymphocyte infiltration mimicking vestibular schwannoma.

Authors:  Gentiana I Wenzel; Friedrich Götz; Thomas Lenarz; Timo Stöver
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-03-04       Impact factor: 2.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.